Omega-3 Ingredients Market

How big is Omega-3 Ingredients Market in 2026?

Sales of omega-3 ingredients are estimated to rise at 10.1% CAGR through 2036. Market valuation increases from USD 9.3 billion in 2025 to USD 10.2 billion in 2026 and is estimated to reach USD 26.8 billion by 2036.

The global omega-3 ingredients market was valued at USD 9.3 billion in 2025 and is estimated to reach USD 10.2 billion in 2026. Growing at 10.1% CAGR between 2026-2036, the market is anticipated to reach USD 26.8 billion by 2036. As per FMI research, eicosapentaenoic acid (EPA) is likely to account for leading share, worth 51.9% of total revenue in 2026. The demand for preformed EPA as well as DHA is supported by the body's limited ability to convert plant-based alpha-linolenic acid (ALA) into these fatty acids [8]. According to GOED, approximately 136,000 metric tons of EPA and DHA ingredients were sold in 2025, representing an increase of 2.6% over the previous year, with China emerging as a key market [1]. Manufacturers are also investing in production and refining capabilities to strengthen their market position. For instance, Epax announced an investment of USD 10 million in January 2025 to establish a new synthesis plant at its Aalesund facility in Norway [4].

Table 1: Market Size and Forecast for the Omega-3 Ingredients Market (USD Billion), 2025 to 2036

Market size and forecast	Value
2025 market size	USD 9.3 billion
Estimated market size in 2026	USD 10.2 billion
Projected market size by 2036	USD 26.8 billion
CAGR (2026-2036)	10.1%
Added revenue, 2026 to 2036	USD 16.6 billion

Key Market Trends & Insights

• By ingredient: The EPA segment is likely to hold leading share of the omega-3 ingredients market in 2026, representing 51.9% of total market revenue.
• By source: Animal-derived omega-3 ingredients, which are primarily obtained from fish oil, are likely to lead with a market share of 46.1% in 2026.
• By application: Dietary supplements are set to hold sway, accounting for 40.5% of the market in 2026.

Regional Highlights

• Fastest-growing country: The United States is expected to record the highest growth rate of all profiled markets, with a projected CAGR of 11.8% between 2026 and 2036.
• Growth across other countries: Germany is projected to expand at a CAGR of 11.5%, followed by South Korea. Japan omega-3 ingredients market is set to grow at 10.2% CAGR.

The availability of raw materials remains an important factor influencing the production and pricing of omega-3 ingredients. According to estimates published by the marine ingredients industry body IFFO, global fish oil production was projected at 1.2 million tonnes in 2025 [2]. However, developments in the fishing industry indicate that raw material availability may remain subject to fluctuations. In 2026, Peru established an anchovy fishing quota of 1.9 million metric tons for its first north-central fishing season, approximately 37% lower than the quota of 3.0 million metric tons recorded in the previous year [3]. Such changes in fishing quotas are likely to influence the supply of fish oil and contribute to fluctuations in ingredient prices.

The market has also experienced changes in pricing and commercial demand. GOED reported that the total value of EPA and DHA ingredients declined by 4.3% to USD 2.53 billion in 2025, primarily because of a correction in ingredient prices. Nevertheless, the organization expects ingredient volumes to increase by approximately 3% to 4% annually through 2028 [1]. Alongside these developments, the supplier landscape has undergone consolidation. In October 2024, KD Pharma completed the acquisition of dsm-firmenich's MEG-3 fish oil business, including its manufacturing facilities in Peru and Canada [7]. This development reflects the continuing efforts of established suppliers to strengthen their production capabilities and market presence.

The development of alternative omega-3 sources is another key development in the market. Algal-derived ingredients are gradually finding applications beyond conventional human nutrition products, especially in pet food. In April 2026, dsm-firmenich introduced Veramaris O3 Max Pure, an algal omega-3 ingredient intended for pet food applications, with an EPA-to-DHA ratio of 3:2 [5]. In addition to pet food, demand from infant and adult nutrition manufacturers also remains relevant to the market. Clover Corporation reported revenue of AUD 44.1 million (approximately USD 30.6 million as of Oct 8, 2026) during the first half of FY2026, representing growth of 17% over the corresponding period [[26].

Table 2: Supporting Industry Indicators for the Omega-3 Ingredients Market (mixed units), 2024 to 2026, mixed years

Indicator	Metric	Why it matters	Source
Ingredient volume	Sales of EPA and DHA ingredients reached 136,000 metric tons in 2025, increasing by 2.6%.	The figure represents the actual quantity of ingredients purchased by manufacturers.	GOED, 2026 Ingredient Market Report, 23 July 2026 [1]
Ingredient value	The value of EPA and DHA ingredients reached USD 2.53 billion in 2025, declining by 4.3% following a price correction.	This provides an external industry benchmark for ingredient market value.	GOED, 2026 Ingredient Market Report, 23 July 2026 [1]
Volume outlook	Ingredient volumes are projected to increase by 3% to 4% annually through 2028.	The forecast provides an external benchmark for expected volume growth.	GOED, 2026 Ingredient Market Report, 23 July 2026 [1]
Raw material output	Global fish oil production was projected to reach 1.2 million tonnes in 2025, with output increasing by 5% during the first three quarters.	Fish oil production determines the availability of an important raw material used in omega-3 ingredients.	Baird Maritime, global fishmeal and fish oil production (IFFO estimates), 29 December 2025 [2]
Raw material quota	Peru established an anchovy fishing quota of 1.9 million metric tons for the first season of 2026, representing a decline of approximately 37%.	Lower fishing quotas may restrict raw material availability and increase pressure on ingredient prices.	SeafoodSource, Peru first anchovy season of 2026, 1 April 2026 [3]
Capacity investment	Epax announced a USD 10 million investment in a new synthesis plant at Aalesund in January 2025.	The investment reflects supplier efforts to expand production and processing capabilities for concentrated ingredients.	Epax, investment announcement, 28 January 2025 [4]
Consolidation	KD Pharma acquired the MEG-3 business from dsm-firmenich on October 1, 2024, while dsm-firmenich received a 29% ownership stake in the parent company.	The transaction indicates continued consolidation among established marine ingredient suppliers.	dsm-firmenich, completion of MEG-3 sale to KD Pharma, 1 October 2024 [7]
Algal product launch	Veramaris O3 Max Pure was introduced for pet food applications in April 2026, with an EPA-to-DHA ratio of 3:2.	The launch demonstrates the expansion of algal omega-3 ingredients into additional customer segments.	dsm-firmenich, Veramaris O3 Max Pure launch, 20 April 2026 [5]
Supplier results	Clover Corporation reported first-half FY2026 revenue of AUD 44.1 million, an increase of 17%, while maintaining full-year revenue guidance of AUD 92 million to AUD 96 million.	The financial results provide an indication of commercial demand from infant and adult nutrition applications.	Small Caps, Clover 1H FY26 results, 24 March 2026 [6]
Regulation	European Union member states approved draft MOAH limits on May 13, 2026, with implementation intended for 2027.	The proposed limits may increase requirements for ingredient testing and purification.	Eurofins, EU adopts MOAH limits for the first time, updated June 2026 [9]
Dosage rule	Supplement labels in the United States should not recommend consumption of more than 2 grams of EPA and DHA per day.	The recommendation influences dosage information for products in the largest application segment.	NIH Office of Dietary Supplements, omega-3 fact sheet for health professionals [8]

Demand Intensity Analysis

A November 2025 review of national guidelines found that 250 mg of EPA and DHA per day was the most common recommendation for healthy adults [10]. Consumption remains below this level for many people. In South Korea, adults aged 19 to 64 consumed an average of 356 mg daily during 2016-2018. However, 68.4% consumed less than 250 mg per day [11]. Raising the 2010 world mean intake of 163 mg to 250 mg per adult per day would require around 649,000 tonnes of supplement oil a year, based on an oil containing approximately 300 mg of EPA and DHA per gram [16]. For comparison, GOED reported worldwide omega-3 ingredient sales of 136,000 tonnes in 2025 [1]. The estimated additional requirement represents approximately 1.4 times this volume when measured as EPA and DHA or 4.8 times when expressed as oil containing 30% EPA and DHA. The quantity of oil required also depends on daily intake. Consuming 250 mg of EPA and DHA per day requires approximately 0.3 kg of standard supplement oil annually. At the 1 g daily intake cited for people with coronary heart disease in the NIH omega-3 guidance [8], annual oil requirements increase to approximately 1.2 kg per person. Higher consumption through supplements and fortified foods would therefore increase the volume of omega-3 ingredients required by manufacturers.

Table 3: Demand Intensity Metrics for the Omega-3 Ingredients Market (EPA and DHA per day unless stated; mixed years: national data 2013 to 2023, global intake 2010, population 2024, ingredient volume 2025)

Demand intensity metric	Value	Basis
Most common adult recommendation	250 mg of EPA and DHA a day	Calder et al., 2025 review [10]
South Korea, adults 19 to 64	Mean 356 mg a day; 68.4% below 250 mg in 2016 to 2018, up from 64.4% in 2007 to 2009	Shim et al. 2023, KNHANES 24-hour recall [11]
Japan, fish and shellfish supply per person	21.4 kg a year in fiscal 2023, down 47% from 40.2 kg in fiscal 2001	Fisheries Agency of Japan, White Paper on Fisheries 2024, edible portion; change calculated [12]
United States, adults eating seafood at least twice a week	24.3% in 2021 to 2023, up from 20.7% in 2013 to 2014	CDC NCHS Data Brief No. 538, NHANES [13]
United Kingdom, adults 19 to 64, oily fish	56 g a week, 40% of the 140 g advised	NDNS 2016/17 to 2018/19 [14]; NHS [15]; ratio calculated
Global mean intake, adults, 2010	163 mg a day, 65% of 250 mg	Micha et al., BMJ 2014 [16]
Population in countries below 250 mg a day, 2010	81.1% (3.58 billion people)	Micha et al., BMJ 2014 [16]
Adults aged 15 and over, 2024	6.13 billion	World Bank: 8.14 billion total less 2.01 billion aged 0 to 14 [17] [18]
Intake shortfall, world mean to 250 mg	87 mg a day per adult; at least 195,000 tonnes of EPA and DHA a year	Calculated for 6.13 billion adults
Same shortfall as supplement oil	About 649,000 tonnes a year	Calculated at 300 mg per gram of oil [8]
Shortfall as a multiple of GOED's 2025 volume	1.4 to 4.8 times	195,000 tonnes if GOED counts content; 649,000 tonnes if it counts oil [1]
Ingredient volume per person, 2025	16.7 g a year (46 mg a day)	GOED's 136,000 tonnes divided by 8.14 billion people [1] [17]
Oil per user a year	0.30 kg at 250 mg a day; 1.22 kg at 1 g a day	Calculated at 300 mg per gram of oil; 1 g is the AHA level for coronary heart disease [8]
What GOED's volume covers	Supplements, pharmaceuticals, food and beverage, pet food, infant formula, clinical nutrition; aquaculture feed oils excluded	GOED, EPA and DHA ingredient market value and volume [19]

Country Comparison

Fish supply per person varies about fourfold across the five countries. South Korea supplies 52.8 kg a year and Japan 45.0 kg, against 21.9 kg in the United States, 17.7 kg in the UK and 13.0 kg in Germany (FAO, 2023) [20]. Japan's own edible-portion count is lower: 21.4 kg in fiscal 2023 [12]. FMI's growth ranking does not follow that order: the United States leads at 11.8% a year to 2036 and Germany follows at 11.5%, ahead of South Korea at 11.2%, Japan at 10.2% and the UK at 9.1% [21]. Dietary fish supply alone therefore does not explain the ranking.

Analyst Perspective

"Over the years of market analysis, I can say that defined potency will continue to increase demand for concentrated omega-3 oils. Algal oil will gain use where product cost and stability remains suitable."

- Nandini Roy Choudhury, Principal Consultant, Future Market Insights.

How is the Omega-3 Ingredients Market segmented?

The market is segmented by ingredient, source, application, and region. Eicosapentaenoic acid is projected at 51.9%, animal sources at 46.1%, and dietary supplements at 40.5% in 2026.

• By ingredient: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA).
• By source: animals (fish oil), algal oil, and plant oils.
• By application: dietary supplements, infant formula, pharmaceutical & nutraceutical products, food industry, beverage industry, and animal feed.
• By region: North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, and Middle East and Africa.

Why do Dietary Supplements lead the Application category?

In 2026, dietary supplements are expected to lead application with 40.5% share, supported by dose-based oils, capsules, and powders.

Dietary supplements are one of the major applications of omega-3 ingredients, as the EPA and DHA quantity can be directly declared in every serving. Capsules are highly used in the market, while powders are increasingly finding application in gummies, sachets and dry formulations. NIH lists fish oil, krill oil, cod liver oil and algal oil among omega-3 supplement formulations, and describes fish oil as one of the most commonly used non-vitamin, non-mineral supplements among US adults and children [8]. Increasing availability of dietary supplements in tablet, capsule, gummy, powder and liquid form is anticipated to drive the dietary supplements segment.

• Growing availability of omega-3 supplements in several dose forms is expected to propel the segment growth.
• Increasing use of liquid oils and protected powders in different supplement products will further support the demand.

Why does Eicosapentaenoic Acid anchor the Ingredients category?

Based on ingredient, eicosapentaenoic acid is projected to account for 51.9% in 2026, driven by defined high-potency dosing needs.

Eicosapentaenoic acid is directly used by manufacturers when a known EPA quantity is required in every serving. Concentrated EPA oils are highly used in high potency capsules and nutraceutical products, as they provide the required dose in lower oil volume. In July 2026, dsm-firmenich stated that life'sOMEGA O33-P100 could deliver up to 500 mg omega-3 in a two-piece gummy serving [22]. Increasing demand for high load gummies, capsules and other smaller dose products is anticipated to support eicosapentaenoic acid segment growth.

• Increasing application of concentrated EPA in gummies, capsules and smaller dose formats is expected to boost the segment growth.
• Availability of application-specific grades and wider use in nutrition products will further support the demand.

What keeps Animals central to the Source category?

By source, animal sources are estimated to hold 46.1% in 2026, owing to established marine refining and concentration capacity.

Animal source omega-3 ingredients are highly used due to the established fish oil extraction, purification and refining industry. Fish oil can be concentrated into different EPA and DHA ratios according to supplements, food and animal nutrition requirements. In August 2026, Epax updated its product specifications and Certificates of Analysis for future European MOAH requirements [23]. Such developments are increasing product documentation and contaminant control, due to which animal sources are expected to retain a prominent share in the market.

• Established marine production capacity and improving contaminant controls are anticipated to support the animal source segment.
• Wider product application and availability of different EPA and DHA ratios are also expected to support the demand.

What are the drivers, restraints, and opportunities in the Omega-3 Ingredients Market?

The key driver is rising use of defined EPA and DHA doses, the restraint is oxidation and compliance cost, and algal supply provides the opportunity.

• Driver: Increasing use of preformed EPA and DHA is supporting demand for oils and concentrates with repeatable potency.
• Restraint: Oxidation, off-flavor, contaminants, and claim requirements may increase formulation cost and delay product launch.
• Opportunity: Algal EPA and DHA is creating new opportunities in vegan supplements, foods, infant nutrition, and pet nutrition.

Defined Potency Requirements Drive Concentrated Omega-3 Demand

Buyers are increasingly preferring preformed EPA and DHA ingredients when the finished product requires a stated long-chain omega-3 quantity. NIH reports that the body's conversion of alpha-linolenic acid into EPA and DHA is very limited, with reported rates below 15% [8]. Due to this, supplement and nutrition manufacturers are using characterized oils instead of depending on precursor conversion. Increasing demand for known potency is expected to drive the omega-3 ingredients market growth.

Oxidation Vulnerability and Claim Substantiation Restraints

Fish oil can form fishy or metallic flavor when the oil oxidizes during storage and formulation. As of 28 February 2025, Japan's Consumer Affairs Agency listed 31 withdrawal requests for foods with function claims containing 500 mg of DHA and EPA, and 27 of those had already been followed by a withdrawal notification [25]. High stability requirements, contaminant testing, and claim review can increase product cost and hamper the omega-3 ingredients market growth.

Microalgal Cultivation Opens New Plant-Based Opportunities

Microalgae provides EPA and DHA without depending on the same marine capture supply. In April 2026, dsm-firmenich launched Veramaris O3 Max Pure with a natural 3:2 EPA to DHA ratio for pet food applications [5]. The familiar ratio allows formulators to consider algal oil in products previously developed with fish oil. Increasing adoption of vegan and traceable omega-3 ingredients is expected to create new avenues for the market. Related demand is visible across diverse specialty lipid applications.

Which country CAGRs are profiled in the Omega-3 Ingredients Market?

Table 4: Country CAGRs for the Omega-3 Ingredients Market (%), 2026 to 2036

Country	CAGR
USA	11.8%
Germany	11.5%
South Korea	11.2%
Japan	10.2%
UK	9.1%

How do country-level CAGRs compare in the omega-3 ingredients market?

Omega-3 ingredient demand is projected to increase across all the profiled countries; however, the factors supporting growth differ from country to country. Large supplement channels are supporting demand in the USA and UK, whereas Germany gives more importance to composition and safety requirements. South Korea has an established health-functional-food category and Japan places higher attention on scientific support for functional claims.

• USA: large supplement demand and defined federal claim treatment support several omega-3 product formats.
• Germany: composition and safety requirements shape which fish, algal or purified oils manufacturers select.
• South Korea: health-functional-food specifications support concentrated EPA and DHA oil use.
• Japan: functional claim review increases the importance of scientific evidence for omega-3 products.
• UK: established capsule, gummy, powder, and liquid supplement formats support ingredient demand.

Full report regional CAGRs cover: North America; Latin America; Western Europe; Eastern Europe; East Asia; South Asia and Pacific; Middle East and Africa.

Country Outlook

• Omega-3 ingredient demand in the USA is forecast to grow at 11.8% CAGR through 2036, owing to the large dietary supplement channel in the country. NIH reports that FDA allowed a qualified health claim in 2004 stating that EPA and DHA may reduce the risk of coronary heart disease, and that supplement labels should not recommend more than 2 g of EPA and DHA a day [8]. The claim route allows manufacturers to communicate specified uses; however, wording and supporting evidence remains controlled. Due to this, manufacturers require a known EPA and DHA assay before deciding the serving size and final label. Increasing adoption of high potency capsules, gummies and practitioner supplements is expected to drive the USA omega-3 ingredients market.
• Germany omega-3 ingredients market is anticipated to grow at 11.5% CAGR through 2036, attributed to established nutrition demand and strict product requirements. Fish supply in Germany, at 13.0 kg per person in 2023, was the lowest of the five profiled countries [20]. Manufacturers select marine, algal or purified oil according to dose and finished product application. Increasing demand for documented purity and correct formulation is anticipated to support the Germany omega-3 ingredients market.
• The South Korea omega-3 ingredients market is estimated to expand at 11.2% CAGR through 2036, supported by the health-functional-food industry. EPA and DHA omega-3 was one of the five most produced health supplements in South Korea in 2025, with production value up 45.7% to KRW 258.1 billion, according to figures from the Ministry of Food and Drug Safety reported by NutraIngredients [24]. Korean adults aged 19 to 64 averaged 356 mg of EPA and DHA a day in 2016 to 2018, and 68.4% were below 250 mg [11]. Presence of a recognized product category is increasing adoption of concentrated oils and is expected to boost the South Korea omega-3 ingredients market.
• At a projected 10.2% CAGR through 2036, Japan's omega-3 ingredient market reflects the influence of established supplement demand and functional claim requirements. Japan's Consumer Affairs Agency recorded 31 withdrawal requests for DHA and EPA (500 mg) foods with function claims by 28 February 2025 [25], and fish and shellfish supply per person fell to 21.4 kg in fiscal 2023 from 40.2 kg in fiscal 2001 [12]. Suppliers and finished-product manufacturers therefore need evidence which supports the intended claim. Increasing demand for supported product claims is anticipated to fuel the Japan omega-3 ingredients market.
• In the UK, omega-3 ingredient demand is predicted to grow at 9.1% CAGR through 2036, aided by established specialty supplement products. The NHS advises at least one portion of oily fish a week, about 140 g cooked [15], while adults aged 19 to 64 averaged 56 g a week in 2016/17 to 2018/19 [14]. This intake gap supports demand across diverse delivery systems including liquid oils and protected powders. Wider supplement application is anticipated to support the UK omega-3 ingredients market.

Who are the notable companies in the Omega-3 Ingredients Market?

dsm-firmenich, Clover Corporation, Croda International plc, Omega Protein Corporation (a Cooke Inc. subsidiary), Nordic Naturals, Copeinca, Epax Norway AS, GC Rieber VivoMega, and Cargill are the notable companies profiled in this market.

Omega-3 ingredients market is moderately fragmented with marine oil companies, algal oil suppliers, powder specialists, and raw-material producers operating in the market. Croda International plc, Epax Norway AS, and GC Rieber VivoMega have marine concentrate products. dsm-firmenich, Cargill, and GC Rieber VivoMega also supply algal omega-3 ingredients. Clover Corporation has protected powder formats, while Omega Protein Corporation (a Cooke Inc. subsidiary) and Copeinca operate closer to marine raw material. Some of the key players are increasing product range, production capacity, and regional distribution in order to cater to the growing demand.

• Concentrated marine EPA/DHA suppliers: Croda International plc, Epax Norway AS, and GC Rieber VivoMega supply high-potency marine concentrates.
• Algal and formulated ingredient suppliers: dsm-firmenich, Clover Corporation, GC Rieber VivoMega, and Cargill provide microalgal oils and protected powder platforms.
• Marine feedstock and raw-material participants: Omega Protein Corporation (Cooke Inc.) and Copeinca (Cooke Inc.) operate closer to primary marine harvesting and oil processing. Nordic Naturals is a finished omega-3 supplement brand that sources marine oils from established suppliers.

Competitive Benchmarking: Omega-3 Ingredients Market

Table 5: Competitive Benchmarking for the Omega-3 Ingredients Market (qualitative ratings), 2026

Company	Marine concentrates	Algal capability	Ingredient formats	Geographic reach
dsm-firmenich	Medium	High	High	High
Clover Corporation	Medium	Medium	High	Medium
Croda International plc	High	Low	Medium	High
Omega Protein Corporation (a Cooke Inc. subsidiary)	Low	Low	Low	Medium
Nordic Naturals	Medium	Low	High	Medium
Copeinca	Low	Low	Low	Medium
Epax Norway AS	High	Low	High	High
GC Rieber VivoMega	High	High	High	High
Cargill	Low	High	High	High

High represents broad public evidence across the stated capability, Medium represents narrower evidence, and Low represents limited documented breadth. These ratings describe public company capability and do not indicate product quality, revenue share, or company ranking.

Key Developments in the Omega-3 Ingredients Market

• In August 2026, Epax Norway AS updated product specifications and Certificates of Analysis for future European MOAH limits [23].
• In July 2026, dsm-firmenich described life'sOMEGA O33-P100 for high-load gummies, delivering up to 500 mg omega-3 in a two-piece serving [22].
• In April 2026, dsm-firmenich launched Veramaris O3 Max Pure for pet food with a natural 3:2 EPA to DHA ratio [5].
• In March 2026, Clover Corporation reported omega-3 growth supported by non-allergenic, higher-fortification, and plant-based powders [26].
• In January 2025, Epax announced a USD 10 million facility investment in Aalesund for synthesis and fractionation technology [4].

Key Players in the Omega-3 Ingredients Market

Concentrated Marine EPA/DHA Suppliers

• Croda International plc
• Epax Norway AS
• GC Rieber VivoMega

Diversified Nutrition and Algal Platforms

• dsm-firmenich
• Clover Corporation
• Cargill

Marine Feedstock and Downstream Participants

• Omega Protein Corporation (a Cooke Inc. subsidiary)
• Copeinca
• Nordic Naturals

Omega-3 Ingredients Market - Report Scope

Table 6: Report Scope for the Omega-3 Ingredients Market (descriptive), 2025 to 2036

Coverage field	Report scope
Market breakdown	Ingredient, Source, Application, and Region
Quantitative units	USD billion
Market definition	Includes bulk, purified, concentrated, and formulated omega-3 ingredients containing EPA, DHA, or ALA. Finished supplements, infant formula, foods, beverages, animal feed, omega-6 products, substitute lipids, and services are excluded.
Regions covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries covered	USA, UK, Germany, Japan, South Korea
Key companies profiled	dsm-firmenich, Clover Corporation, Croda International plc, Omega Protein Corporation (a Cooke Inc. subsidiary), Nordic Naturals, Copeinca, Epax Norway AS, GC Rieber VivoMega, Cargill
Forecast period	2026 to 2036
Approach	Primary and secondary research with market triangulation

Omega-3 Ingredients Market - Research Methodology

Table 7: Research Methodology for the Omega-3 Ingredients Market (descriptive), 2025 to 2036

Method	Approach
Primary Research	The research study includes interviews with manufacturers, distributors, end users, procurement teams, and industry experts. Interviews cover purchasing decisions, product evaluation, pricing, adoption barriers, and approval requirements.
Desk Research	Desk research includes government statistics, regulatory publications, trade data, industry associations, technical literature, company filings, product pages, and company announcements.
Market Sizing and Forecasting	The market model uses baseline value, historical performance, segment structure, pricing, volume indicators, company participation, and country demand. Forecast assumptions include regulation, technology use, supply, and purchasing conditions.
Data Validation	Market estimates are compared with public data, company activity, trade patterns, and primary interviews. Adjacent products and overlapping revenue are excluded from the market size.

Omega-3 Ingredients Market by Segments

Omega-3 Ingredients Market segmented by Ingredient:

• Eicosapentaenoic Acid (EPA)
• Docosahexaenoic Acid (DHA)
• Alpha-Linolenic Acid (ALA)

Omega-3 Ingredients Market segmented by Source:

• Animals (Fish Oil)
• Algae (Algal Oil)
• Plants
  • Chia Seed Oil
  • Flax Seed Oil
  • Walnut Oil
  • Canola Oil
  • Soybean Oil
  • Mustard Oil

Omega-3 Ingredients Market segmented by Application:

• Dietary Supplements
• Infant Formulas
• Pharmaceutical & Nutraceutical Industry
• Food Industry (Breakfast Cereals, Bakery & Confectionery, Dairy Desserts, Savory Snacks)
• Beverage Industry (Functional Drinks, Juices)
• Animal Feed

Omega-3 Ingredients Market by Region

• North America
  • United States
  • Canada
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Chile
• Western Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Benelux
  • Nordics
• Eastern Europe
  • Poland
  • Czech Republic
  • Romania
  • Hungary
• East Asia
  • Japan
  • South Korea
• South Asia and Pacific
  • ASEAN
  • Australia and New Zealand
• Middle East and Africa
  • GCC Countries
  • South Africa
  • Türkiye
  • Israel

Research Sources and Bibliography

1. GOED - GOED Publishes 2026 Ingredient Market Report (23 July 2026)
2. Baird Maritime - Global fishmeal and fish oil production sees rise in 2025 (29 December 2025)
3. SeafoodSource - Peru launches first North-Central anchovy season of 2026 with decreased TAC of 1.9 million tons (1 April 2026)
4. Epax - Investing $10 million to boost innovation and sustainability drive (28 January 2025)
5. dsm-firmenich - dsm-firmenich launches Veramaris O3 Max Pure at Petfood Forum 2026 (20 April 2026)
6. Small Caps - Clover Corporation Posts Strong 1H FY26 Results with Maintained FY26 Guidance (24 March 2026)
7. dsm-firmenich - dsm-firmenich completes the sale of its MEG-3 fish oil business to KD Pharma Group (1 October 2024)
8. NIH Office of Dietary Supplements - Omega-3 Fatty Acids: Fact Sheet for Health Professionals
9. Eurofins - EU adopts MOAH limits for the first time (updated June 2026)
10. Calder P.C. et al. - An overview of national and international long chain omega-3 polyunsaturated fatty acid intake recommendations for healthy populations, Nutrition Research Reviews 39:e6 (24 November 2025)
11. Shim J.E., Lee Y., Song S. - Trends in dietary intake and food sources of long-chain polyunsaturated fatty acids among Korean adults between 2007 and 2018, Epidemiology and Health 45:e2023069 (1 August 2023)
12. Fisheries Agency of Japan (MAFF) - White Paper on Fisheries, fiscal 2024 edition, Part 1 Chapter 1, trends in seafood consumption (in Japanese)
13. CDC National Center for Health Statistics - Seafood Consumption Among Youth and Adults: United States, August 2021-August 2023, NCHS Data Brief No. 538 (4 September 2025)
14. National Diet and Nutrition Survey, Years 9 to 11 (2016/17 to 2018/19) summary, as hosted by the British Nutrition Foundation
15. NHS - Fish and shellfish nutrition (page last reviewed 26 June 2026)
16. Micha R. et al. - Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys, BMJ 348:g2272 (2014)
17. World Bank - Population, total, World, 2024
18. World Bank - Population ages 0-14, total, World, 2024
19. GOED - What is the value and volume of the EPA and DHA omega-3 ingredient market?
20. FAO Food Balances, via Our World in Data - Fish and seafood supply per person, 2023
21. Future Market Insights - Omega-3 Ingredients Market
22. dsm-firmenich - life'sOMEGA innovations named NutraIngredients-USA Award finalists (8 July 2026)
23. Epax Norway AS - Updating for future MOAH requirements (26 August 2026)
24. NutraIngredients - South Korea's top five most produced health supplements in 2025 (2 June 2026)
25. Consumer Affairs Agency, Japan - Foods with Function Claims, withdrawal request table as of 28 February 2025 (in Japanese)
26. Clover Corporation - 1H FY26 results announcement to the ASX (24 March 2026)

This Report Answers

• How large is the Omega-3 Ingredients Market in 2026 and what value is forecast for 2036?
• Which factors support omega-3 ingredient demand in nutrition products?
• Why does eicosapentaenoic acid hold a notable ingredient share?
• Why do animal sources hold a notable source share?
• Which country has a notable omega-3 ingredient growth outlook?
• Which companies are active in the Omega-3 Ingredients Market?